Why Walgreens Boots Alliance Stock Was Sliding Today
Shares of Walgreens Boots Alliance (NASDAQ: WBA) pulled back today after the company again ran into trouble with regulators. On Friday, the Department of Justice (DOJ) filed a lawsuit against Walgreens,
Uncover the Reason: Why Walgreens Boots Alliance Inc (WBA) Stock Is Trading 54.95% Above Its 52-Week Low?
Walgreens Boots Alliance Inc (WBA) stock saw a decline, ending the day at $12.52 which represents a decrease of $-0.41 or -3.17% from the prior close of $12.93. The stock opened at $13.03 and touched a low of $12.
Walgreens Boots Alliance (WBA) Gets a Hold from Evercore ISI
In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Walgreens Boots Alliance (WBA – Research
After Crashing 64% in 2024, Can Walgreens Boots Alliance Stock Turn Things Around This Year?
To say that pharmacy retailer Walgreens Boots Alliance (NASDAQ: WBA) has been struggling would be a massive understatement. It's coming off a horrendous year in 2024, when its share price crashed by 64%.
This Is What Whales Are Betting On Walgreens Boots Alliance
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Walgreens Boots Alliance's whale activity within a strike price range from $7.5 to $12.5 in the last 30 days.
Walgreens Boots Alliance (WBA) Gets a Buy from TD Cowen
TD Cowen analyst Charles Rhyee maintained a Buy rating on Walgreens Boots Alliance (WBA – Research Report) today and set a price target of
Can Walgreens Boots Alliance Stock Keep Soaring?
Can Walgreens Boots Alliance stock continue rising, or should investors use the stock's recent gain as an opportunity to exit? Let's look at what the pharmacy chain operator said in its latest report to see whether it's time to buy, sell, or hold the ultra-high-yield dividend stock.
Walgreens stock opens lower after opioid lawsuit allegations
Shares of Walgreens Boots Alliance (NASDAQ:WBA) fell by 6% following allegations by the U.S. Justice Department that the pharmacy chain dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (CSA) and the False Claims Act (FCA).
Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound
After a tough year for Walgreens investors in 2024, could the stock be poised for a rebound in 2025? Analysts have remained ...
Walgreens Boots Alliance price target raised to $12 from $9 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on Walgreens Boots Alliance (WBA) to $12 from $9 and keeps a Sector Perform ...
Walgreens: Share Price Spike On Recovery Plan Success May Be Sustainable
Walgreens Boots Alliance surged by >25% today, following strong Q1 2025 earnings and revenue outperformance. Click here to ...
Walgreens Is Soaring on Friday. Here's Why The Beaten-Down Healthcare Stock Bounced.
However, shareholders finally got a reason to smile when the company reported its latest results. Walgreens beat expectations ...
Nasdaq11d
Walgreens Boots Alliance Reaches Analyst Target Price
In recent trading, shares of Walgreens Boots Alliance Inc (Symbol: WBA) have crossed above the average analyst 12-month target price of $9.87, changing hands for $11.76/share. When a stock ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation - WBA
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an ...